Care Health Insurance reported a 44% year-on-year jump in September premium income, reaching a Gross Direct Premium Income of ₹1,042 crore. While the company has secured its position as India’s second-largest standalone health insurer, investors should note it remains an unlisted entity. Challenges such as high claim costs and rising medical inflation continue to put pressure on overall profitability despite strong revenue growth.
Care Health Insurance has reported a 44 percent year-on-year growth in its September premium income, posting a Gross Direct Premium Income (GDPI) of ₹1,042 crore. This performance outperforms the general insurance industry, which saw an average growth rate of 27 percent. For the first half of the 2027 financial year, the company's cumulative GDPI climbed to ₹6,193 crore, marking a 42 percent increase compared to the same period in the previous year.
With a 3.45 percent market share, Care Health Insurance is now established as the second-largest standalone health insurer in India. The company has aggressively expanded its infrastructure, operating 288 branches and maintaining over 22,040 hospital tie-ups as of the first quarter of fiscal 2027. This rapid expansion in service and distribution network is a central part of the company's strategy to capture more market share in the growing health insurance segment.
Despite this strong revenue growth, the company’s financial health faces clear challenges. In the previous financial year (FY26), Care Health Insurance reported a significant decline in net profit—dropping by approximately 92 percent. This sharp fall occurred even as revenue grew, driven primarily by higher claim settlements and increased operational costs. For investors looking at the company, this highlights the difference between top-line expansion and actual profitability.
The health insurance sector is currently grappling with rising medical inflation and higher claim ratios, which pressure underwriting margins. The company's profitability is also sensitive to market fluctuations, as it relies on investment income to offset underwriting losses. Additionally, the broader insurance industry is navigating regulatory scrutiny regarding commission structures and new guidelines on co-payments, which could further impact future cost structures.
It is essential for investors to understand that Care Health Insurance is an unlisted company. It does not trade on public stock exchanges like the NSE or BSE. While it is a subsidiary of the listed entity Religare Enterprises Limited, its own shares are available only in the unlisted or private market. This often results in lower liquidity compared to publicly traded stocks, meaning it can be harder to buy or sell these shares quickly.
The most important factor for investors to track moving forward is the company’s ability to improve underwriting profitability. The success of the business will depend on managing its claim ratios more effectively and sustaining margins against rising medical costs. Continued regulatory updates regarding the health insurance sector will also play a major role in how the company operates in the coming quarters.